Aquestive Therapeutics Inc (AQST)

CapEx to Revenue

1.53%

Quarterly · Period ending:

AQST logo

AQST CapEx to Revenue

Latest reported1.53%
AQST Quarterly CapEx/Revenue (4.00% → 1.53%)
High-resolution chart · PNG

AQST capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aquestive Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
1.5341%
0.36%
0.6531%
1.8349%
1.0697%
1.5482%
0.1264%
0.5908%
0.1741%
0.2406%
0.1212%
1.1614%
6.2382%
0.018%
0.2434%
14.9786%
5.1037%
0.8476%
4.8113%
0.6247%
1.2643%
0.9261%
3.3012%
0.46%
0.5167%
1.4946%
0.5238%
0.7328%
0.9884%
2.974%
2.9125%
3.3768%
4.5017%
1.1063%
0.7216%
1.5951%
7.9878%
3.9973%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.